Ignite Creation Date:
2025-12-24 @ 9:41 PM
Ignite Modification Date:
2026-03-11 @ 4:15 AM
Study NCT ID:
NCT01727232
Status:
COMPLETED
Last Update Posted:
2012-11-15
First Post:
2012-11-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Rituximab Given at Fixed Dose (1000 mg on Days 1 and 15) Compared to the Standard Regimen in Adult's Immune Thrombocytopenia
Sponsor:
Henri Mondor University Hospital
Organization: